Meldonium: 27 Russian sportspeople test positive for banned drug

Meldonium, also known as mildronate, was banned by the World Anti-Doping Agency on 1 January

Twenty-seven Russian sportspeople have tested positive for meldonium this year, according to the Russian sports minister.

Tennis player Maria Sharapova failed a doping test after the World Anti-Doping Agency banned the drug on 1 January.

Four Russian athletes, who have not been named, tested positive for the substance this week.

"Twenty-seven have tested positive for meldonium and there are some 127 cases in the world," said Vitaly Mutko.

Russia's athletics federation is suspended from international competition for its alleged involvement in widespread doping, with a decision on potential reinstatement due in May.

Dmitry Shlyakhtin, head of the All-Russia Athletic Federation, said the latest positive tests will not "aggravate" that "complex" decision.

Russia's international ban - which includes this summer's Rio Olympic Games - applies only to its athletics federation and followed an independent World Anti-Doping Agency report last year that alleged "state-sponsored doping".

Thought to improve stamina and endurance
Designed to treat ischemia and used by diabetes suffers
Banned by Wada since 1 January 2016
Featured on Wada's watch list in 2015

Last week, Russia's four-time breaststroke world champion Yuliya Efimova failed an out-of-competition test.

World number seven Sharapova, meanwhile, failed a drugs test at the Australian Open.

The 28-year-old said she had been taking meldonium since 2006 for health reasons.

According to Wada, a substance may be "considered" for the prohibited list if it meets two of the following three criteria:

  • Enhances performance
  • Poses a threat to athlete health
  • Violates the spirit of sport

A substance can be added to the prohibited list without first featuring on the watch list.

Grindeks, the Latvian company that produces the drug, says meldonium can take "several months" to leave the body.

It said the "terminal elimination" of the drug depends on a variety of factors such as dose, duration of treatment and sensitivity of testing methods.

Top Stories

Elsewhere on the BBC